Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy.
The intrathecal synthesis of antibodies against recombinant VP1, the major structural protein of JC virus (JCV), was studied in 18 patients with progressive multifocal leukoencephalopathy (PML) and in 31 patients with various neurological disorders. Two methods were used, the calculation of an antibody specific index (ASI) on one hand and an antigen-driven immunoblotting for the detection of oligoclonal antibodies on the other. Most PML patients displayed an elevated (> 1.5) ASI (78%) and anti-VP1 oligoclonal antibodies restricted to the cerebrospinal fluid (55%). Only two other patients (one case each of multiple sclerosis and of neuroborreliosis) also showed an intrathecal synthesis of anti-VP1 oligoclonal antibodies, likely as a result of a 'polyspecific' reaction within the central nervous system.
Sindic
C J
CJ
Laboratoire de Neurochimie, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. sindic@nchm.ucl.ac.be
Trebst
C
C
Van Antwerpen
M P
MP
Frye
S
S
Enzensberger
W
W
Hunsmann
G
G
Lüke
W
W
Weber
T
T
D000914:Antibodies, Viral / Q000134:cerebrospinal fluid*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D015151:Immunoblotting; D007577:JC Virus / Q000276:immunology*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology; D015678:Viral Structural Proteins / Q000276:immunology*
D000914:Antibodies, Viral; D011994:Recombinant Proteins; D015678:Viral Structural Proteins